Ankylosing Spondylitis
Remicade approved for spinal illness, new warning added to label
Published in Pharma Law Weekly, January 11th, 2005
At the same time, Centocor, Inc., said it is adding a new label warning about possible liver damage from the pharmaceutical, which is also used in the treatment of rheumatoid arthritis and Crohn's disease. Centocor is a unit of Johnson & Johnson.
Ankylosing spondylitis is a progressive inflammatory condition that can result in fusion of the spine and damage to hips and other joints.
It usually affects people under age 35. The Spondylitis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-01-11)
More Articles from Pharma Law Weekly
- Acacia Research Corp.
CombiMatrix and NDC achieve milestone with delivery of prototype workstation - Basilea Pharmaceutica
U.S. trade commission ends waiting period for drug companies' collaboration - Chronic Care
Cigna HealthCare to provide services for Medicare's chronic care program - Diatos, SA
DTS-201 moves toward clinical trials in Europe - Genta, Inc.
Company acquires c-myb antisense drug from Temple University - GeoPharma, Inc.
Company announces litigation relating to announcement of Mucotrol's clearance - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
